在聚山梨酯存在的金属催化氧化条件下,减少的IgG1抗体左旋反平行β-片结构稳定性发生

IF 4.5 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Mari Lehtimaki, Uriel Ortega-Rodriguez, Garrick Centola and V. Ashutosh Rao*, 
{"title":"在聚山梨酯存在的金属催化氧化条件下,减少的IgG1抗体左旋反平行β-片结构稳定性发生","authors":"Mari Lehtimaki,&nbsp;Uriel Ortega-Rodriguez,&nbsp;Garrick Centola and V. Ashutosh Rao*,&nbsp;","doi":"10.1021/acs.molpharmaceut.5c0003410.1021/acs.molpharmaceut.5c00034","DOIUrl":null,"url":null,"abstract":"<p >Polysorbates are common surfactants in monoclonal antibody (mAb) drug products. While polysorbates assist in stabilizing and refolding proteins, oxidative stress conditions can reduce protein stability wherein polysorbate binds to the oxidized and unfolded protein. We investigated the effects of polysorbates on the higher-order structural stability of mAbs under oxidative conditions that may occur during manufacturing, storage, and use. Secondary and tertiary structures of trastuzumab and rituximab products were investigated under two oxidative conditions: metal-catalyzed oxidation (MCO; CuSO<sub>4</sub> and ascorbic acid) and 2,2′-azobis (2-aminidinopropane) dihydrochloride (AAPH) using either polysorbate-containing formulations or after polysorbate depletion. Higher-order structures were predicted from the collected circular dichroism spectra with an algorithm optimized for β-sheet structural predictions. Secondary structure analyses using circular dichroism at increasing temperatures demonstrated that MCO and AAPH triggered differing β-sheet structure degradation patterns. Rituximab products were more sensitive to MCO compared with trastuzumab products as shown by left-twisted antiparallel β-sheet structure loss and increase in unstructured elements at lower temperatures. AAPH-exposed drugs tended to have distinct unfolding states compared with the MCO-treated drugs as shown by the increase in parallel β-sheet structures for AAPH and decreased parallel β-sheet structures with MCO. Polysorbate depletion transiently improved the stability of MCO-treated material as shown by delayed circular dichroism (CD) signal degradation at 202 nm and improved peak area of the antibody monomer by nonreducing capillary electrophoresis sodium dodecyl sulfate (nrCE-SDS) and peak intensity of intact antibody in matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) analysis. The improved stability of detergent-depleted material is traced to improved stability in the predicted left-twisted β-sheet structural elements. Our data further highlights the need for formulation studies that consider the impact of polysorbate binding and/or degradation for specific drug products under stress conditions such as metal-catalyzed oxidation.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":"22 5","pages":"2623–2638 2623–2638"},"PeriodicalIF":4.5000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reduced IgG1 Antibody Left-Twisted Antiparallel β-Sheet Structure Stability Occurs under Metal-Catalyzed Oxidation Conditions in the Presence of Polysorbates\",\"authors\":\"Mari Lehtimaki,&nbsp;Uriel Ortega-Rodriguez,&nbsp;Garrick Centola and V. Ashutosh Rao*,&nbsp;\",\"doi\":\"10.1021/acs.molpharmaceut.5c0003410.1021/acs.molpharmaceut.5c00034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Polysorbates are common surfactants in monoclonal antibody (mAb) drug products. While polysorbates assist in stabilizing and refolding proteins, oxidative stress conditions can reduce protein stability wherein polysorbate binds to the oxidized and unfolded protein. We investigated the effects of polysorbates on the higher-order structural stability of mAbs under oxidative conditions that may occur during manufacturing, storage, and use. Secondary and tertiary structures of trastuzumab and rituximab products were investigated under two oxidative conditions: metal-catalyzed oxidation (MCO; CuSO<sub>4</sub> and ascorbic acid) and 2,2′-azobis (2-aminidinopropane) dihydrochloride (AAPH) using either polysorbate-containing formulations or after polysorbate depletion. Higher-order structures were predicted from the collected circular dichroism spectra with an algorithm optimized for β-sheet structural predictions. Secondary structure analyses using circular dichroism at increasing temperatures demonstrated that MCO and AAPH triggered differing β-sheet structure degradation patterns. Rituximab products were more sensitive to MCO compared with trastuzumab products as shown by left-twisted antiparallel β-sheet structure loss and increase in unstructured elements at lower temperatures. AAPH-exposed drugs tended to have distinct unfolding states compared with the MCO-treated drugs as shown by the increase in parallel β-sheet structures for AAPH and decreased parallel β-sheet structures with MCO. Polysorbate depletion transiently improved the stability of MCO-treated material as shown by delayed circular dichroism (CD) signal degradation at 202 nm and improved peak area of the antibody monomer by nonreducing capillary electrophoresis sodium dodecyl sulfate (nrCE-SDS) and peak intensity of intact antibody in matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) analysis. The improved stability of detergent-depleted material is traced to improved stability in the predicted left-twisted β-sheet structural elements. Our data further highlights the need for formulation studies that consider the impact of polysorbate binding and/or degradation for specific drug products under stress conditions such as metal-catalyzed oxidation.</p>\",\"PeriodicalId\":52,\"journal\":{\"name\":\"Molecular Pharmaceutics\",\"volume\":\"22 5\",\"pages\":\"2623–2638 2623–2638\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-04-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5c00034\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5c00034","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

聚山梨酯是单克隆抗体(mAb)药物制品中常见的表面活性剂。虽然聚山梨酸酯有助于稳定和重新折叠蛋白质,氧化应激条件可以降低蛋白质的稳定性,其中聚山梨酸酯与氧化和未折叠的蛋白质结合。我们研究了聚山梨酸酯对单克隆抗体在制造、储存和使用过程中可能发生的氧化条件下的高阶结构稳定性的影响。在两种氧化条件下研究了曲妥珠单抗和利妥昔单抗产品的二级和三级结构:金属催化氧化(MCO;CuSO4和抗坏血酸)和2,2 ' -偶氮(2-氨基丙烷)二盐酸(AAPH)使用含有聚山梨酸酯的配方或在聚山梨酸酯耗尽后。利用优化后的β-薄片结构预测算法,对所收集的圆二色光谱进行了高阶结构预测。在温度升高时,利用圆二色性进行二级结构分析表明,MCO和AAPH引发了不同的β-片结构降解模式。与曲妥珠单抗产品相比,利妥昔单抗产品对MCO更敏感,表现为在较低温度下左扭曲反平行β-片结构损失和非结构化元件增加。与MCO处理的药物相比,AAPH暴露的药物倾向于具有不同的展开状态,这表明AAPH的平行β-片结构增加,而MCO的平行β-片结构减少。聚山梨酯耗损可瞬间改善mco处理材料的稳定性,如202 nm处延迟圆二色性(CD)信号降解,非还原毛细管电泳十二烷基硫酸钠(nrCE-SDS)抗体单体峰面积和基质辅助激光解吸电离飞行时间(MALDI-TOF)完整抗体峰强度的提高。减少洗涤剂的材料稳定性的提高可以追溯到预测的左扭β片结构元素的稳定性的提高。我们的数据进一步强调了需要进行配方研究,考虑在压力条件下(如金属催化氧化)聚山梨酸酯结合和/或降解对特定药物产物的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Reduced IgG1 Antibody Left-Twisted Antiparallel β-Sheet Structure Stability Occurs under Metal-Catalyzed Oxidation Conditions in the Presence of Polysorbates

Reduced IgG1 Antibody Left-Twisted Antiparallel β-Sheet Structure Stability Occurs under Metal-Catalyzed Oxidation Conditions in the Presence of Polysorbates

Polysorbates are common surfactants in monoclonal antibody (mAb) drug products. While polysorbates assist in stabilizing and refolding proteins, oxidative stress conditions can reduce protein stability wherein polysorbate binds to the oxidized and unfolded protein. We investigated the effects of polysorbates on the higher-order structural stability of mAbs under oxidative conditions that may occur during manufacturing, storage, and use. Secondary and tertiary structures of trastuzumab and rituximab products were investigated under two oxidative conditions: metal-catalyzed oxidation (MCO; CuSO4 and ascorbic acid) and 2,2′-azobis (2-aminidinopropane) dihydrochloride (AAPH) using either polysorbate-containing formulations or after polysorbate depletion. Higher-order structures were predicted from the collected circular dichroism spectra with an algorithm optimized for β-sheet structural predictions. Secondary structure analyses using circular dichroism at increasing temperatures demonstrated that MCO and AAPH triggered differing β-sheet structure degradation patterns. Rituximab products were more sensitive to MCO compared with trastuzumab products as shown by left-twisted antiparallel β-sheet structure loss and increase in unstructured elements at lower temperatures. AAPH-exposed drugs tended to have distinct unfolding states compared with the MCO-treated drugs as shown by the increase in parallel β-sheet structures for AAPH and decreased parallel β-sheet structures with MCO. Polysorbate depletion transiently improved the stability of MCO-treated material as shown by delayed circular dichroism (CD) signal degradation at 202 nm and improved peak area of the antibody monomer by nonreducing capillary electrophoresis sodium dodecyl sulfate (nrCE-SDS) and peak intensity of intact antibody in matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) analysis. The improved stability of detergent-depleted material is traced to improved stability in the predicted left-twisted β-sheet structural elements. Our data further highlights the need for formulation studies that consider the impact of polysorbate binding and/or degradation for specific drug products under stress conditions such as metal-catalyzed oxidation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Pharmaceutics
Molecular Pharmaceutics 医学-药学
CiteScore
8.00
自引率
6.10%
发文量
391
审稿时长
2 months
期刊介绍: Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信